−Removed: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
−Removed: MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
+Added: Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information for Common Stock
−Removed: Prior to November 13, 2023, our common stock traded on
−Removed: the Nasdaq Capital Market under the symbol SQLL.
−Removed: Nasdaq suspended trading in our common stock effective at the open of trading on November 13,
−Removed: 2023 due to our failure to comply with Nasdaq Listing Rule 5550(a)(4), which required us to have a minimum of 500,000 publicly-held shares
−Removed: of common stock, exclusive of shares held by officers, directors and 10% stockholders.
−Removed: Since November 13, 2023, our common stock
−Removed: has been listed for quotation on the OTC Pink Market under the trading symbol “SEQL.”.
−Removed: Trading in our common stock in the
−Removed: over-the-counter market has been limited and the quotations for our common stock on the OTC Pink Market are not necessarily indicative
−Removed: of actual market values.
−Removed: During the period from November 13, 2023 to April 1, 2024, the high and low closing bid price of our common stock
−Removed: on the OTC Pink Market was $6.60 and $1.40 respectively.
−Removed: All quotations for the OTC Pink Market reflect inter-dealer prices, without retail
−Removed: mark-up, mark-down or commission and may not necessarily represent actual transactions.
−Removed: On April 1, 2024, the closing bid price for our common stock on the
−Removed: OTC Pink Market as reported by the quotation service operated by the OTC Markets Group was $1.40.
−Removed: As of April 1, 2024, there were approximately 17 stockholders of record,
−Removed: according to the records of our transfer agent, and an unknown number of additional holders of common stock held in ‘street name’.
+Added: Prior to November 13, 2023, our common stock traded on the Nasdaq Capital Market under the symbol SQLL.
+Added: Pursuant to the terms of the Merger, the Company changed its corporate name from SeqLL Inc.
+Added: to Atlantic International Corp.
+Added: and its trading symbol to ATLN.
+Added: Our common stock was originally listed for quotation on the OTC Pink Market.
+Added: Trading in our common stock in the over-the-counter market was limited and the quotations for our common stock on the OTC Pink Market were not necessarily indicative of actual market values.
+Added: On December 11, 2024, we started trading on the Nasdaq Global Select Market.
+Added: During the period from June 18, 2024 to December 31, 2024, the high and low closing bid price of our common stock was $8.97 and $2.36 respectively.
+Added: All quotations for the OTC Pink Market reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.
+Added: On March 21, 2025, the closing stock price for our common stock on the Nasdaq Global Select Market was $6.20.
+Added: As of March 21, 2025, there were approximately 336 stockholders of record, according to the records of our transfer agent, and in excess of 500 additional holders of common stock held in ‘street name’.
We have not declared any common stock dividends to date.
−Removed: present intention of paying any cash dividends on our common stock in the foreseeable future, as we intend to use earnings, if any, to
−Removed: generate growth.
−Removed: The payment by us of dividends, if any, in the future, is within the discretion of our board of directors and will depend
−Removed: upon, among other things, our earnings, capital requirements and financial condition, as well as other relevant factors.
−Removed: material restrictions in our Certificate of Incorporation, as amended, or Bylaws that restrict us from declaring dividends.
+Added: We have no present intention of paying any cash dividends on our common stock in the foreseeable future, as we intend to use earnings, if any, to generate growth.
+Added: The payment by us of dividends, if any, in the future, is within the discretion of our board of directors and will depend upon, among other things, our earnings, capital requirements and financial condition, as well as other relevant factors.
+Added: There are no material restrictions in our Certificate of Incorporation, as amended, or Bylaws that restrict us from declaring dividends.
Unregistered Sales of Equity Securities
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.